Does USTEKINUMAB Cause Thrombocytosis? 20 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Thrombocytosis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.0% of all adverse event reports for USTEKINUMAB.
20
Reports of Thrombocytosis with USTEKINUMAB
0.0%
of all USTEKINUMAB reports
0
Deaths
15
Hospitalizations
How Dangerous Is Thrombocytosis From USTEKINUMAB?
Of the 20 reports, 15 (75.0%) required hospitalization, and 7 (35.0%) were considered life-threatening.
Is Thrombocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 20 reports have been filed with the FAERS database.